cute abdominal pain in pregnant patients presents a difficult diagnostic challenge. The differential diagnosis during pregnancy is extensive in that the abdominal pain may be obstetric in nature or may be caused by disease of other intraabdominal or intrapelvic structures [1] . Because of the anatomic and physiologic changes that occur with pregnancy, localization of disease can be difficult. The use of conventional radiographic imaging is constrained because of the risk of harm to the fetus by ionizing radiation [2, 3] .
The use of CT is well established in the evaluation of acute abdominal pain [4, 5] . CT provides excellent anatomic detail, but a considerable dose of ionizing radiation is conferred to the fetus, making this technique undesirable. Sonography is a safe, versatile imaging technique to use in pregnant patients and is often the first imaging technique used in a pregnant patient with abdominal pain. However, in the presence of a gravid uterus, intraabdominal organs may be displaced and challenging to visualize on sonography [6] .
MRI provides a good overall topographic display and high intrinsic soft-tissue contrast. MRI also benefits from lack of ionizing radiation [6, 7] , making it safe to use in pregnant patients. Although a number of prior reports have shown the ability of MRI to evaluate the fetus using current short-duration sequences [8, 9] , there are fewer reports describing the investigation of maternal abdominal and pel-A vic disease on MRI. The purpose of this study was to evaluate the ability of MRI to show causes of acute abdominal and pelvic pain in pregnant patients. To our knowledge, this study is the first in which pregnant patients with acute abdominal or pelvic pain were prospectively evaluated using MRI.
Subjects and Methods Patients
All abdominal and pelvic MRI studies of pregnant patients who were referred for examination because of acute abdominal or pelvic pain between June 2002 and May 2004 were included (n = 29). The term "acute pain" was defined as pain that was sudden in onset and had been present for 72 hr or less. The mean patient age was 25 years (range, 18-35 years), and the mean gestational age was 23 weeks (range = 10-36 weeks). The use of MRI in these patients was at the discretion of the clinician.
All patients underwent fetal sonographic examination before any other imaging. Six of the 29 patients also underwent complete abdominal sonographic examination before MRI. In the remaining 23 patients, MRI was the choice for primary imaging. Prospective clinical MR interpretations were compared with medical, surgical, and obstetric records when applicable. All patients were followed up until the date of article submission or until the date of the final chart entry (mean follow-up time, 4.1 months; range, 0.5-11 months). The nature of the MRI examination and its associated risks and benefits were explained to all patients before the study, and signed consent was obtained from all patients.
In 22 of the 29 patients, gadolinium was not administered. In the examinations performed with gadolinium (n = 7), the risks and benefits of administration of gadolinium were discussed beforehand in detail with the patient and the ordering clinician. The mean gestational age of patients receiving gadolinium was 27 weeks (range, 13-31 weeks). No bowel preparation was used in any study. All MRI studies were performed for clinical indications, so institutional review board (IRB) approval was obtained for case review. A signature waiver was also obtained in accordance with IRB regulations and the Health Insurance Portability and Accountability Act.
MR Technique
All patients were imaged at the University of North Carolina (UNC) at Chapel Hill or the University of California, San Diego (UCSD). MR examinations of the abdomen and pelvis were performed on a 1.5-T system (VISION or Sonata [UNC] or Symphony [UCSD], Siemens Medical Solutions). All MR examinations were performed using a set protocol including unenhanced T1-weighted images, acquired as a breath-hold spoiled gradientecho sequence (TR range/TE range, 120-170/4.0-4.5; flip angle, 80-90°), and T2-weighted HASTE images (TR/effective TE, infinite/90; 2-3 acquisitions). Section thickness was 7-10 mm, and the matrix size was 128-192 × 256 (phase × frequency encoding) for all sequences.
Immediately after unenhanced images were obtained, an experienced radiologist with fellowship training in body MRI reviewed the images to determine whether a diagnosis could be established without the administration of IV gadolinium chelate (gadodiamide, Omniscan, Amersham Health). In 22 of the 29 MR examinations, gadolinium was not administered. In seven examinations, gadolinium was administered in a dosage of 0.1 mmol/kg as a rapid bolus injection. Serial spoiled gradientecho images were acquired at 18 sec (late hepatic arterial-arterial-dominant phase) and at 45-60 sec (venous phase). A 90-to 120-sec postinjection fatsuppressed spoiled gradient-echo sequence was also acquired. The total examination time was less than 20 min for all studies that did not include IV contrast administration.
Image Interpretation
All MR examinations were interpreted in a clinical setting at the time of examination by experienced radiologists with fellowship training in body MRI. Radiologists were not blinded to clinical information. Unenhanced images were reviewed first to determine whether a diagnosis could be made without the administration of gadolinium. The same criteria and descriptions of various diseases used in nonpregnant patients [10] [11] [12] [13] [14] [15] [16] [17] were used to establish a diagnosis. Medical, surgical, and obstetric records were reviewed to determine the correctness of the clinical MR interpretations. Two radiologists later reviewed the images to obtain measurements and grade signal intensity of visualized disease processes if these determinations were not included in the original clinical interpretations.
Results
The following disease processes were identified using MRI: appendiceal abscess (n = 1) ( Fig. 1) , appendicitis (n = 2), intraabdominal and rectus muscle abscess (n = 1), intussusception (n = 1) (Fig. 2) , pancreatitis (n = 1), ulcerative colitis (n = 1) (Fig. 3 ), Crohn's disease with diffuse peritoneal inflammation (n = 1) (Fig. 4) , bilateral adrenal hemorrhage (n = 1), pyelonephritis (n = 2) (Fig. 5 ), hydronephrosis (n = 1), uterine fibroid degeneration (n = 2), degeneration and torsion of a subserosal uterine fibroid (n = 1), simple ovarian cysts (n = 1), and ovarian torsion (n = 1) (Fig. 6 ). Twelve MR examinations were interpreted as normal. The patients who received IV gadolinium (n = 7) were those with MR diagnoses of appendicitis, appendiceal abscess, ulcerative colitis, Crohn's disease, pyelonephritis (both patients), and hydronephrosis.
The prospective clinical MR interpretations and follow-up medical records were congruent in 28 of 29 patients. The MR interpretations accurately described the type of disease in all but one patient. That particular patient was at 18 weeks' gestation and was referred for MR examination because of acute right lower quadrant pain. Multiple right ovarian cysts were identified on MRI. One month after the MR examination, laparoscopy revealed a torsed right ovary with multiple cysts. The finding of torsion on MRI was neither described prospectively nor seen in retrospect.
MR diagnoses of appendiceal abscess, appendicitis, rectus muscle abscess, intussusception, ovarian torsion, ovarian cyst, uterine fibroid degeneration, and torsed uterine fibroid were confirmed by surgical and pathologic findings. MR diagnoses of Crohn's disease and ulcerative colitis were confirmed by colonic biopsy. Patients with diagnoses of adrenal hemorrhage, pancreatitis, pyelonephritis, and hydronephrosis were confirmed by clinical or laboratory findings (or both). MR diagnosis of ovarian cyst was confirmed with additional imaging postpartum. All patients with MR examinations interpreted as showing normal findings had unremarkable clinical courses according to the follow-up records. No patient with normal findings on MRI was found to have subsequent abdominal or pelvic disease.
The clinical courses for those patients who underwent complete abdominal sonographic examination before MRI are described later; those patients are the ones with remarkable clinical events.
In one patient with pelvic pain at 32 weeks' gestation, MRI showed degeneration and suspected torsion of a subserosal uterine fibroid. Sonography revealed a parauterine mass without Doppler flow but did not show the origin of the mass. MRI showed a clear connection of the mass to the uterus by a narrow pedicle and normal ovaries. Laparotomy revealed a torsed subserosal fibroid rotated 360° on a very narrow stalk. The patient and infant are well to date.
In one patient with epigastric pain at 35 weeks' gestation, sonographic examination revealed sludge in the gallbladder, mild common bile duct dilatation, and partial visualization of a normal-appearing pancreas. The MR examination revealed an abnormal pancreas and surrounding free fluid consistent with pancreatitis. Laboratory values supported the diagnosis of pancreatitis. The patient developed preterm labor the same day and delivered a premature but healthy infant.
In three patients with suspected appendicitis, sonographic examination did not depict the appendix. In the first patient, subsequent MR examination showed a normal appendix. In the second patient, MR examination did not reveal the appendix but did show a lack of pericecal fat stranding. In the third patient, MRI revealed an acutely inflamed, fluidfilled appendix with periappendiceal fat stranding. An open appendectomy was performed, and pathology findings confirmed acute appendicitis. All three patients had uneventful deliveries of healthy infants.
In one patient with abdominal and flank pain at 31 weeks' gestation, sonographic examination showed hydronephrosis. The patient underwent MRI to exclude renal abscess. MRI showed hydronephrosis without evidence of pyelonephritis. On the basis of these findings, the patient was treated supportively.
One patient at 31 weeks' gestation was found to have an appendiceal abscess on MR examination. The patient underwent an open appendectomy the next day. The operative notes reported frank pus, a large abscess cavity, and a perforated appendix. At 39 weeks' gestation, the patient underwent uneventful elective repeat cesarean delivery of a healthy infant.
In one patient with diffuse abdominal pain at 13 weeks' gestation, MRI showed findings consistent with ulcerative colitis. The patient was treated with oral steroids. The patient delivered at 35 weeks because of the premature rupture of membranes. Later, colonic biopsy confirmed ulcerative colitis. The infant is healthy to date.
One patient at 31 weeks' gestation was referred for MR examination because of severe upper abdominal pain. MR images revealed bilateral adrenal hemorrhage. The patient was treated with replacement corticosteroids. The patient underwent term elective cesarean de- In one patient at 15 weeks' gestation and right lower quadrant pain, MR images showed an intraabdominal and rectus muscle abscess. An abdominal drain was placed into the abscess and remained until labor developed at 36 weeks. The patient underwent cesarean delivery of a premature but healthy infant. A laparoscopic enterolysis performed 3 weeks later revealed a large cavity adherent to the abdominal wall in the right lower quadrant, pericecal inflammation, and a small perforation in the ileum. The patient and infant are well to date.
Discussion
Although there is substantial literature supporting the ability of MRI to evaluate abdominal and pelvic disease [10] [11] [12] [13] [14] [15] [16] , there are fewer reports that describe its use in pregnant patients [17] [18] [19] . Results of this current study show the ability of MRI to accurately characterize abdominal and pelvic disease in pregnant patients with acute abdominal or pelvic pain. MRI has been shown to be a useful imaging technique for imaging the adrenal gland [10, 11] and in the diagnosis of appendicitis [12, 13] , inflammatory bowel disease [14, 15] , pancreatitis [16] , intussusception [18] , hydronephrosis and pyelonephritis [20, 21] , uterine fibroids [22] , and adnexal masses [23] . In our study, we used the same criteria A, Transverse HASTE image shows bowel wall thickening (arrows). B, Transverse fat-suppressed image obtained after gadolinium administration shows moderately intense mucosal and serosal enhancement (arrows) of bowel, which is consistent with acute active disease. Submucosal sparing, as shown in this case, is consistent with ulcerative colitis rather than Crohn's disease, which generally shows transmural involvement. 
B A

and descriptions of various diseases to establish a diagnosis in pregnant patients.
Acute appendicitis is the most common nonobstetric surgical condition occurring in the obstetric patient population [1, 24] . Anatomic alterations in the location of the appendix accompany an enlarging uterus, usually in the cephalad direction. With appendicitis, a fetal loss rate of less than 2% is observed with an unruptured appendix, and with a ruptured appendix, the rate is more than 30% [25] . The diagnosis is commonly missed in pregnant patients because leukocytosis occurs physiologically during pregnancy and may be overlooked; nausea and emesis are common symptoms of appendicitis but are common during pregnancy; and the location of pain is often not typical [26] . The patient in our study with an appendiceal abscess had cephalad extension of the abscess to a subhepatic location (Fig. 1) .
Inflammatory bowel disease, including Crohn's disease and ulcerative colitis, is also a diagnostic challenge during pregnancy [17] . As in appendicitis, many symptoms typical of pregnancy (nausea, emesis, abdominal discomfort) may also be signs of active inflammatory bowel disease. MRI findings such as bowel wall thickening and mucosal enhancement can be seen in inflammatory bowel disease (Figs. 3 and 4) . The pharmacologic treatment of inflammatory bowel disease is limited during pregnancy, but in patients with this disease, it is paramount to evaluate for bowel obstruction, abscess, bleeding, and toxic megacolon. Mucosal biopsy is needed to confirm the diagnosis of Crohn's disease or ulcerative colitis.
MRI has been shown to be useful in characterizing uterine fibroids during pregnancy [27] . Leiomyomas (fibroids) tend to become smaller during pregnancy, and some involute completely. However, large fibroids can undergo hemorrhagic infarction, which results in pain. Premature labor may ensue as a consequence [28] . Subserosal fibroids can undergo torsion and degeneration during pregnancy. MRI of one patient in our study showed a subserosal uterine mass with signal intensity typical of a degenerating fibroid. Although torsion was suspected because Doppler flow was absent on sonography and a narrow stalk was seen on MRI, a more definitive diagnosis of torsion may have been achieved with gadolinium administration. However, discussion with the clinicians after unenhanced imaging indicated that management would not be affected.
Most adnexal masses in pregnancy are asymptomatic [1] and are discovered incidentally during routine sonography examination. The management of painful adnexal masses, however, is controversial. Most adnexal masses are nonneoplastic cysts [1] . Cystic teratomas and cystadenomas are the most common benign ovarian neoplasms during pregnancy [29] . Three percent of ovarian masses during pregnancy are malignant [29] . Torsion must also be considered in pregnant patients because enlargement of the uterus causes a shift in the position of adnexal structures that may then become torsed. The MRI appearance of ovarian torsion is well described [30] . Solid ovarian tissue appears enlarged and edematous. This appearance was observed in one case of ovarian torsion in our series (Fig. 6) . In another patient, torsion was not identified, which we believe was due to the fact that the ovary was largely cystic, and therefore edematous tissue was not seen. Torsion of adnexal masses occurs more commonly during pregnancy, and the MRI appearance of torsed and nontorsed structures can be similar. We believe it is important to consider torsion when adnexal masses are discovered in pregnant patients with severe abdominal or pelvic pain.
The most recent available figure for the incidence of acute pancreatitis in pregnant patients is one in 3,333 [31] . Its presentation in pregnancy is similar to that in nonpregnant patients. Gallstones, as in nonpregnant patients, are the most common cause of pancreatitis during pregnancy [32] . Pancreatitis may also be caused by biliary sludge [33] , as we believe occurred in the patient in our study. Maternal mortality is low in uncomplicated pancreatitis, but it is greater than 10% in complicated pancreatitis. The initial diagnosis of pancreatitis is usually clinical, but MRI is useful for characterizing complicated pancreatitis [16] . Adrenal hemorrhage is rare during pregnancy. Most reported cases are associated with preeclampsia or eclampsia, shock, septicemia, and trauma [34] . MR images of the patient in our study showed bilateral adrenal enlargement and signal characteristics consistent with hemorrhage. As in our patient, subsequent adrenal insufficiency may develop, and treatment with replacement corticosteroids is vital.
Hydronephrosis and hydroureter occur in 70-90% of pregnancies likely because of mechanical obstruction from an enlarged uterus or diminished muscle tone in the urinary tract from hormonal changes associated with pregnancy [35] . In severe cases, patients may develop ureteral obstruction and require ureteral stents or nephrostomy tubes. Acute pyelonephritis occurs in 1-2% of pregnancies and may result from asymptomatic bacteriuria [35] , common in pregnancy. Pyelonephritis (Fig. 5) is associated with premature labor [36] and is important to exclude in pregnant patients.
Gadodiamide (Omniscan, Amersham Health) is a pregnancy category C drug. It is known to cross the placenta and has been shown to increase skeletal malformations in animal studies (Omniscan, Amersham Health). No controlled longterm studies in pregnant patients have been performed, but it is suggested that gadodiamide be used only during the second and third trimesters of pregnancy and only when the benefits outweigh the risks (Omniscan package insert, Amersham Health). In our study, initial unenhanced images were reviewed in all cases to determine whether a diagnosis could be made without contrast administration. In all cases in which gadolinium was administered, its risks and benefits were discussed in detail with both the patient and the ordering clinician before administration. Longterm animal studies have not been performed to evaluate its carcinogenic potential, but no carcinogenic effects have yet been shown (Omniscan package insert, Amersham Health).
The U.S. Food and Drug Administration guidelines require that MRI devices be labeled to indicate that the safety of MRI with respect to the fetus has not been established [37] . The safety concern arises from the tissue heating effect caused by radiofrequency pulses, which are maximal at the body surface and approach zero near the body core [38] . No adverse fetal effects from MRI have been documented to date. It is generally accepted that MRI should be used judiciously in preg- 
nant patients when benefits outweigh risks as with all imaging techniques [38] . However, we should stress that the single greatest factor in morbidity and mortality of the pregnant patient is delay in diagnosis [39] .
One important limitation of our study is the small number of patients. It would be of interest to study a larger population of pregnant patients in the same prospective manner to confirm our initial findings. Furthermore, this study did not include all pregnant patients who presented to our medical centers with acute abdominal or pelvic pain. A blinded prospective study of all these patients would be necessary to further solidify the role of MRI in the evaluation of these patients. Lastly, our study was not performed as a comparison of imaging techniques; instead, we evaluated patients specifically referred for MRI by a clinician. MRI has an established role in the investigation of abdominal and pelvic disease at our centers, and direct referral to MRI by clinicians is not rare. In the future, we believe a comparative study of sonography and MRI would be useful.
In summary, our results show that MRI can be used to identify a wide variety of abdominal and pelvic disease processes in pregnant patients with acute abdominal or pelvic pain. This prospective study shows that abdominal and pelvic diseases in pregnant patients can be well evaluated on MRI. MRI accurately depicted various forms of abdominal and pelvic disease and affected patient management. Correlation with medical records showed correct identification of disease entities in all cases with the exception one, a case of ovarian torsion that was not apparent on MRI.
The pregnant patient with acute abdominal or pelvic pain presents a unique diagnostic challenge. The intrinsic safety and accuracy of MRI in diagnosing abdominal and pelvic disease in pregnant patients make it an excellent choice in the evaluation of these patients.
